Health condition
Eye lymphoma
Lymphoma affects the eye in two distinct patterns - indolent ocular adnexal lymphoma of the conjunctiva and orbit, and aggressive vitreoretinal lymphoma inside the eye that masquerades as uveitis and is closely tied to CNS lymphoma.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
A salmon-pink conjunctival patch or painless orbital swelling suggests adnexal (MALT) lymphoma
-
Chronic "uveitis" in older adults resisting steroids should raise suspicion of vitreoretinal lymphoma
-
Vitreous biopsy establishes the intraocular diagnosis; MRI and lumbar puncture assess the brain
-
Adnexal MALT lymphoma is often cured with low-dose radiotherapy alone
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
The two diseases could hardly differ more. Ocular adnexal lymphoma - usually MALT type - grows lazily in the conjunctiva, eyelid or orbit, sometimes visible as a fleshy salmon-coloured patch, occasionally linked to chlamydial infection or autoimmune disease. Primary vitreoretinal lymphoma, by contrast, is a high-grade B-cell disease seeding the vitreous and retina, classically misdiagnosed for months as posterior uveitis in a patient over sixty whose inflammation improves on steroids only to rebound.
Diagnosis and treatment routes
Management diverges accordingly: localised adnexal MALT disease is typically eradicated with modest-dose orbital radiotherapy, with rituximab-based options for wider involvement. Vitreoretinal lymphoma is treated as a sibling of primary CNS lymphoma - intravitreal methotrexate or rituximab controls the eye, but the decisive question is brain involvement now or later, driving systemic high-dose methotrexate strategies and vigilant neurological surveillance in joint ophthalmology-haematology care. If you are waiting for results or want a second opinion on a proposed plan, a private consultation with a specialist who treats this condition regularly can usually be arranged quickly, and most will review your existing scans, biopsy reports and MDT correspondence.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant ophthalmologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about Eye lymphoma.
Quick, plain-English answers to what people ask us most.
-
What is eye lymphoma?
Eye lymphoma is a diagnosis used by clinicians to describe a specific pattern of symptoms or findings. It's usually confirmed after a proper assessment, since several conditions can look similar at first.
-
Why does eye lymphoma happen?
Eye lymphoma can arise from several different underlying mechanisms, and in many cases more than one factor contributes. Identifying likely causes usually forms part of the initial specialist work-up.
-
How would I know if I have eye lymphoma?
Symptoms of eye lymphoma vary from person to person and can range from mild and easily missed to significant enough to affect daily life. Because overlapping conditions can produce similar symptoms, a clinical assessment is the most reliable way to confirm what's actually going on.
-
How dangerous is eye lymphoma?
Eye lymphoma is a serious diagnosis that needs prompt, specialist-led assessment and a clear treatment plan. Outcomes depend heavily on factors such as how early it's found and how it responds to treatment, which is why timely investigation matters.
-
Is eye lymphoma hereditary?
In most cases eye lymphoma isn't straightforwardly inherited, though family history can sometimes be a relevant background factor. A clinician can help you understand whether it's worth mentioning relatives' health when being assessed.
-
Is eye lymphoma treatable?
Treatment for eye lymphoma depends on the stage and type at diagnosis, and can include surgery, medical therapy, radiotherapy or a combination, sometimes with curative intent and sometimes focused on control and quality of life. A multidisciplinary specialist team is best placed to explain realistic goals for your specific case.
-
How is eye lymphoma treated?
Treatment for eye lymphoma is usually built around the severity of your symptoms and any underlying cause found on assessment, and may involve lifestyle measures, medication, physiotherapy or, in some cases, a procedure. Your specialist will discuss the pros and cons of each option with you before agreeing a plan.
-
What's the outlook for eye lymphoma?
The outlook for eye lymphoma varies widely depending on the underlying cause, how early it's diagnosed, and how it responds to treatment. Many people see significant improvement with appropriate care, and your specialist can give you a more personalised timeframe once they've reviewed your case.
-
When is surgery needed for eye lymphoma?
Whether surgery plays a role in treating eye lymphoma depends on factors such as stage, location and overall health, and is decided by a multidisciplinary team weighing up the likely benefits against the risks. Non-surgical options are often used alongside or instead of surgery depending on the individual case.
-
When should I see a doctor about eye lymphoma, and how quickly can I be seen privately?
It's worth seeking medical advice if symptoms of eye lymphoma are persistent, worsening, or affecting your daily life, rather than waiting for them to resolve on their own. NHS routine referrals for this kind of assessment can take anywhere from around 20 to 45+ weeks, whereas private consultants typically offer an appointment within about two weeks.